AzTrials
AzTrials

BreastfeedingNCT05796284

Effects of Breast Intervention During the Late Pregnancy on the Parturients' Breast Engorgement,Maternal Competence,and Stress

A study testing Breast pressure relief intervention at the end of pregnancy and Routine care in people with Breastfeeding and Pregnancy Related, run by National Defense Medical Center, Taiwan at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study purpose is to examine the effects of breast tenderness relief intervention during the late pregnancy on the parturients' breast engorgement, lactation, breastfeeding, maternal competence, and stress. Read more about this study

Who is it for?
Ages 20 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Breastfeeding, Pregnancy Related, Efficacy, Self
What is being tested?
Breast pressure relief intervention at the end of pregnancy and Routine care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteTaiwan
Study dates
1 Aug 2023to 31 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 1. Healthy pregnant women over 20 years old, without mental illness, and the number of pregnancy weeks has reached 36 weeks; 2. Full term production; 3. Literate or able to communicate in Chinese and Taiwanese; 4. After explaining, agree to participate in the research, sign the consent form, and accept long-term follower

Who cannot join

  • Pregnant women with a history of smoking, alcohol, and drug abuse;
  • Pregnant women have mental illness;
  • Maternal complications during childbirth or postpartum, such as: postpartum hemorrhage, infection, etc.;
  • Newborns with congenital abnormalities and major diseases;
  • Pregnant women who are unable or unwilling to breastfeed due to illness or other factors;
  • Refuse to accept breast compression intervention will be excluded from participating in the study

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • National defense medical center

    Taipei, Taiwan, 114201

Other trials in Taiwan

About this study

Official title: Effects of Breast Tenderness Relief Intervention During the Late Pregnancy on the Parturients' Breast Engorgement, Lactation, Breastfeeding, Maternal Competence, and Stress

The study purpose is to examine the effects of breast tenderness relief intervention during the late pregnancy on the parturients' breast engorgement, lactation, breastfeeding, maternal competence, and stress.

Read the detailed description

Background:

Maternal and child health is an important global health issue. Breast milk is the best food for infants and has many benefits for both mothers and infants. However, the breastfeeding rate in Taiwan has not increased but decreased in recent years. Breast engorgement and hypogalactia often cause distress for many women, and lead to stress and abandonment of breastfeeding, which in turn affects the achievement of motherhood. Therefore, nurses should provide support interventions for parturients early.

Methods:

This study is a two-years, prospective randomized controlled trial, and will adopt a longitudinal repeated-measures design. Convenience sampling will be used to recruit 180 pregnancy and postpartum women in the obstetrics clinic and postpartum ward of a medical center. The participants will be randomly assigned into two conditions (routine care and the breast tenderness relief intervention condition). The intervention will be provided to the participants from the 36th week of pregnancy until three months after delivery. Questionnaires, and biological measurements will be used to collect data. The outcome variables include the degree of breast engorgement, lactation, breastfeeding, maternal competencies, and stress. In addition, those data will be collected at the 36th and 38th week of pregnancy, three days, six weeks, and twelve weeks after childbirth. It is expected to analyze the research results with generalized estimation equation method.

Being tested
Breast pressure relief intervention at the end of pregnancy, Routine care
Keywords
breast tenderness relief intervention, breast engorgement, breastfeeding, maternal efficacy
Medical subject headings
Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Breast pressure relief intervention at the end of pregnancyBehavioural

    When teaching pregnant women, the researchers will use tablet computers and models to explain the operation of breast combing and acupressure one-on-one, and use the model to demonstrate. Emphasis on breast grooming during pregnancy, twice a day, once in the morning and evening, 5 minutes on one breast each time, 10 minutes on both sides; strengthen breast grooming and acupressure after delivery. The first breast combing, 5 minutes on one breast each time, and 10 minutes on both sides 4 to 6 times a day. After combing, according to expert advice, massage the 6 acupoints around the breast for 5-10 seconds, and then use hand expressing or breastfeeding to discharge the milk .

  • Routine careOther

    Cases in the routine care group received routine prenatal care and guidance during weekly outpatient checkups, and routine postpartum care and guidance after delivery.

Study groups in NCT05796284
Study groupRoleWhat they receive
Breast pressure relief intervention at the end of pregnancyExperimentalThe "Breast Compression Intervention at the End of Pregnancy" group is expected to start after the 36th week of pregnancy and continue until three months after delivery. In addition to routine care, breast relaxation methods of different intensities during pregnancy and postpartum will be provided in stages.
Receives: Behavioral: Breast pressure relief intervention at the end of pregnancy; Other: Routine care
Routine care groupActive comparatorCases in the routine care group receive routine prenatal care and guidance during weekly outpatient checkups, and routine postpartum care and guidance after delivery, including breastfeeding posture and skills, hand expression, and breast milk storage methods, etc.
Receives: Other: Routine care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. breast engorgement

    the late pregnancy on the parturients' breast engorgement

    Measured: Change from Baseline breast engorgement at 12 weeks after delivery.

  2. The volume and speed of lactation

    the late pregnancy on the parturients' lactation

    Measured: Change from Baseline lactation at 12 weeks after delivery.

  3. Breastfeeding Self-efficacy Scale Short Form

    the late pregnancy on the parturients' breastfeeding

    Measured: Change from Baseline Breastfeeding Self-efficacy at 12 weeks after delivery.

  4. Parental Self-efficacy Scale

    the late pregnancy on the parturients' maternal competence

    Measured: Change from Baseline Parental self-efficacy at 12 weeks after delivery.

  5. Perceived Stress Scale

    late pregnancy on the parturients' stress

    Measured: Change from Baseline Perceived Stress Scale at 12 weeks after delivery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2023
  2. Study start1 Aug 2023
  3. Primary completion31 Jul 2024
  4. Study completion31 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
160 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05796284
Sponsor's protocol ID
C202205166
Status last verified
May 2024
First submitted
16 Feb 2023
Last updated
7 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Breast pressure relief intervention at the end of pregnancy and Routine care in people with Breastfeeding and Pregnancy Related, run by National Defense Medical Center, Taiwan at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

breast engorgement (time frame: Change from Baseline breast engorgement at 12 weeks after delivery.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in